(IN BRIEF) A prototype of the Liverpool Diagnostic Infrared Wand (LDIR Wand), developed by the University of Liverpool in collaboration with the Liverpool Head and Neck Cancer Centre, has shown promising results in diagnosing oral cancer. The device uses a … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged cancer diagnosis, cancer prognosis, Cancer Research UK, clinical application, commercialization, early cancer detection, funding, haematoxylin and eosin staining, i4i programme, infrared spectral images, LDIR Wand, Liverpool Diagnostic Infrared Wand, Liverpool Head and Neck Cancer Centre, machine learning algorithm, National Institute for Health and Care Research, oral cancer, Professor Peter Weightman, Professor Richard Shaw, technological innovation, tissue analysis, University of Liverpool, “prototype”
(IN BRIEF) The University of Glasgow is pioneering a project to use cosmic rays for non-invasive structural assessments of the UK’s ageing transport infrastructure. Led by Dr. David Mahon and supported by a £459,000 grant from UKRI’s Science and Technology … Read the full press release
Posted in Education, Industrial, Infrastructure & Utilities, Technology, United Kingdom
Tagged 3D imaging, carbon footprint, commercialization, cosmic rays, Dr. David Mahon, Early Detection, Glasgow, infrastructure monitoring, Lynkeos Technology Ltd, Machine Learning, muography, muons, net-zero goals, Non-Destructive Testing, road and rail bridges, Science and Technology Facilities Council, STFC, structural fatigue, structural integrity, sustainability, Transport Scotland, UK transport infrastructure, UKRI, University of Glasgow
(IN BRIEF) The European Investment Bank (EIB) has awarded Belgium-based medtech company Nyxoah €37.5 million in venture-debt financing to support the development of innovative treatments for obstructive sleep apnea (OSA). This funding, backed by the InvestEU Life Sciences programme, will … Read the full press release
Posted in Banks, Belgium, European Union, Financial, Healthcare, Pharma & Biotech
Tagged Belgium, commercialization, EIB, equity offering, Europe, European Investment Bank, financing, Genio system, hypoglossal neurostimulation therapy, INNOVATION, InvestEU, InvestEU Life Sciences programme, life sciences, manufacturing capacity, medtech, Nyxoah, obstructive sleep apnea, Olivier Taelman, OSA, production capacity, research and development, Robert de Groot, technological innovation, US, venture-debt financing
(IN BRIEF) Sanofi has simplified its contractual arrangements with AstraZeneca and Sobi for the development and commercialization of Beyfortus (nirsevimab) in the United States. Under the new arrangements, Sanofi will have full commercial control of nirsevimab in the U.S. Sanofi … Read the full press release
Posted in Business, France, Healthcare, Industrial, Management, News, Pharma & Biotech
Tagged AstraZeneca, Beyfortus, commercialization, contractual agreements, nirsevimab, partnership, Sanofi, Sobi, USA
(PRESS RELEASE) GENEVA, 29-Apr-2022 — /EuropaWire/ — SGS, the world’s leading testing, inspection and certification company, has announced the company won five awards at the 2022 CRO Leadership Awards underlining its industry-leading work. The categories the company won award in … Read the full press release
Posted in Awards, Business, Industrial, Management, News, Science, Switzerland, Technology
Tagged analytical testing, Antwerp University Hospital, Awards, Clinical Pharmacology Unit, clinical research, commercialization, cro, CRO Leadership Awards, CRO Quality Benchmarking, CROs, Ed Miseta, Health Science, Industry Standard Research, Johan Pype, life sciences, Manufacturing, SGS, survey
(COMMUNIQUÉ DE PRESSE) GENEVA, 29-Apr-2022 — /EuropaWire/ — SGS, le leader mondial des tests, de l’inspection et de la certification, a annoncé que la société a remporté cinq prix aux CRO Leadership Awards 2022, soulignant son travail de pointe dans … Read the full press release
Posted in Awards, Business, Industrial, Management, News, Science, Switzerland
Tagged analytical testing, Antwerp University Hospital, Awards, Clinical Pharmacology Unit, clinical research, commercialization, cro, CRO Leadership Awards, CRO Quality Benchmarking, CROs, Ed Miseta, Health Science, Industry Standard Research, Johan Pype, life sciences, Manufacturing, SGS
Further strengthens core R&D areas of autoimmune and allergic diseases Provides full control of brain-penetrant BTK inhibitor SAR442168 in multiple sclerosis (MS), making commercialization more efficient and eliminating future royalty payments Allows expansion of SAR442168 development program into other central … Read the full press release
Posted in Business, France, Healthcare, Investment, News, Pharma & Biotech
Tagged acquisition, allergic diseases, Arnaud Delepine, Ashleigh Koss, autoimmune diseases, biopharmaceutical, BofA Securities, Bruton tyrosine kinase, BTK inhibitor, BTK inhibitor ‘168, Centerview Partners LLC, Christopher Chai, commercialization, Cooley LLP, Eva Schaefer-Jansen, Evercore, Fara Berkowitz, Felix Lauscher, Gotshal & Manges LLP, John Reed M.D. Ph.D., Martin Babler, MS, multiple sclerosis, Nicolas Kressmann, pathophysiology, Paul Hudson, Paul Laland, Pharmaceutical, Principia, Principia Biopharma, PRN473 Topical, rilzabrutinib, Sanofi, SAR442168, Suzanne Greco, Weil, Yvonne Naughton
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?